Patents Assigned to EMBRIENT, INC.
-
Publication number: 20250387427Abstract: A method of treatment is presented for alleviating and/or repairing damage associated with M1 macrophage driven inflammation through administration of high molecular weight hyaluronic acid (HMW-HA), optionally in combination with platelet-rich plasma (PRP) and/or anti-Stabilin-2 antibodies. Preferred embodiments are formulated for parenteral administration and either directly or indirectly suppress M1 macrophage activity, and/or directly indirectly promote M2 macrophage polarization.Type: ApplicationFiled: August 27, 2025Publication date: December 25, 2025Applicant: Embrient, Inc.Inventor: Barry E. Rothenberg
-
Publication number: 20250084361Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: ApplicationFiled: November 21, 2024Publication date: March 13, 2025Applicant: Embrient, Inc.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
-
Patent number: 12173269Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: GrantFiled: March 28, 2023Date of Patent: December 24, 2024Assignee: Embrient, Inc.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
-
Patent number: 11884910Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: GrantFiled: August 3, 2023Date of Patent: January 30, 2024Assignee: Embrient, Inc.Inventors: Kyong-su Son, Royal Q. Le, Barry E. Rothenberg
-
Publication number: 20230374437Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: ApplicationFiled: August 3, 2023Publication date: November 23, 2023Applicant: Embrient, Inc.Inventors: Kyong-su Son, Royal Q. Le, Barry E. Rothenberg
-
Publication number: 20230242861Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: ApplicationFiled: March 28, 2023Publication date: August 3, 2023Applicant: Embrient, Inc.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
-
Patent number: 11634681Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: GrantFiled: May 16, 2022Date of Patent: April 25, 2023Assignee: EMBRIENT, INC.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
-
Publication number: 20220275322Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: ApplicationFiled: May 16, 2022Publication date: September 1, 2022Applicant: Embrient, Inc.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
-
Patent number: 11365385Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.Type: GrantFiled: November 10, 2021Date of Patent: June 21, 2022Assignee: EMBRIENT, INC.Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son